HETEROGENEOUS IMMUNOGLOBULIN GENE REARRANGEMENT IN A B-CHRONIC LYMPHOCYTIC-LEUKEMIA PROGRESSING INTO NON-HODGKIN LYMPHOMA (RICHTER SYNDROME)

被引:0
|
作者
KERIM, S
GEUNA, M
DICELLE, PF
CARBONE, A
PONTI, R
NOVERO, D
FOA, R
PALESTRO, G
机构
[1] UNIV TURIN,HUMAN ONCOL SECT,I-10126 TURIN,ITALY
[2] UNIV TURIN,PATHOL SECT,I-10126 TURIN,ITALY
[3] UNIV TURIN,CLIN SECT,I-10126 TURIN,ITALY
[4] UNIV TURIN,CNR,CTR IMMUNOGENET & HISTOCOMPATIBIL,I-10126 TURIN,ITALY
关键词
IMMUNOGLOBULIN REARRANGEMENT; MOLECULAR BIOLOGY; B-CHRONIC LYMPHOCYTIC LEUKEMIA; RICHTER SYNDROME;
D O I
10.1002/1097-0142(19930115)71:2<359::AID-CNCR2820710215>3.0.CO;2-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The relationship between chronic lymphocytic leukemia (CLL) and supervening non-Hodgkin lymphoma is debated, as is whether a particular genomic pattern is related to the emergence of the terminal lymphoma. To investigate these features, the molecular organization of the immunoglobulin (Ig) gene region in a case during both the B-CLL and Richter transformation phase was studied. Methods. B-CLL and non-Hodgkin lymphoma cells were processed for Southern blot analysis of Ig heavy-and light-chain gene configuration. Results. Molecular studies of B-CLL cells revealed the presence of a single Ig heavy-chain rearrangement with both kappa and lambda light-chain rearranged genes, which was consistent with the occurrence of multiple mutational events during the development of the B-CLL clone. Molecular analysis of the lymphoma DNA showed new Ig heavy- and kappa light-chain rearrangements in addition to the original ones related to the CLL phase, indicating that the lymphoma tissue consisted of two genotypically distinct populations of cells. Conclusions. On the basis of the overall molecular Configuration, this heterogeneous pattern of Ig gene rearrangement was interpreted as an inherent genetic instability of the CLL clone, in which multiple mutational events allowed a selective pressure toward more aggressive subclones, resulting in the emergence of the terminal lymphoma.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [31] FLUDARABINE IN PATIENTS WITH ADVANCED AND OR RESISTANT B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    ZINZANI, PL
    LAURIA, F
    RONDELLI, D
    BENFENATI, D
    RASPADORI, D
    BOCCHIA, M
    GOZZETTI, A
    CAVO, M
    CIRIO, TM
    ZAJA, F
    RUSSO, D
    FANIN, R
    GALIENI, P
    ALGERI, R
    FIACCHINI, M
    TURA, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1993, 51 (02) : 93 - 97
  • [32] Hodgkin’s lymphoma as Richter’s transformation in chronic lymphocytic leukemia
    Alberto Fabbri
    Emanuele Cencini
    Monica Bocchia
    Medical Oncology, 2014, 31
  • [33] Hodgkin's lymphoma as Richter's transformation in chronic lymphocytic leukemia
    Fabbri, Alberto
    Cencini, Emanuele
    Bocchia, Monica
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [34] Transformation from chronic lymphocytic leukemia to classical Hodgkin lymphoma: an unusual Richter syndrome variant
    Li, Kaimin
    Liu, Jing
    Li, Weilong
    Zhou, Qin
    Jiang, Lei
    Chu, Xiaoxia
    Pan, Xubo
    Qu, Guimei
    Xu, Junqing
    Yu, Guohua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 12703 - +
  • [35] Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Elefante, Anjana
    Czuczman, Myron S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (09) : 713 - 723
  • [36] A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma
    Van der Jagt, R.
    Laneuville, P.
    MacDonald, D.
    Stewart, D.
    Christofides, A.
    Sehn, L. H.
    CURRENT ONCOLOGY, 2012, 19 (03) : 160 - 168
  • [37] Zanubrutinib: A Novel BTK Inhibitor in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
    Tam, Constantine S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 32 - 34
  • [38] Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Cerhan, JR
    Vachon, CM
    Habermann, TM
    Ansell, SM
    Witzig, TE
    Kurtin, PJ
    Janney, CA
    Zheng, W
    Potter, JD
    Sellers, TA
    Folsom, AR
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1466 - 1471
  • [39] Malignant fibrous histiocytoma in the setting of chronic lymphocytic leukemia and non-Hodgkin lymphoma
    Kubica, Agnieszka
    Weaver, Amy
    Brewer, Jerry
    Rose, Peter
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB167 - AB167
  • [40] A Highly Complex Karyotype in a Case of Non-Hodgkin Lymphoma/Chronic Lymphocytic Leukemia
    Mitter, N. S.
    McMorrow, L.
    Heil, M.
    CYTOGENETIC AND GENOME RESEARCH, 2014, 142 (03)